Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 19 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

5%

1 trials in Phase 3/4

Results Transparency

0%

0 of 5 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

13Total
Not Applicable (9)
P 1 (2)
P 2 (1)
P 3 (1)

Trial Status

Recruiting8
Not Yet Recruiting5
Completed5
Enrolling By Invitation1

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 5 completed trials

Clinical Trials (19)

Showing 19 of 19 trials
NCT07095023Not ApplicableRecruitingPrimary

Neoadjuvant Oral Paclitaxel Plus Subcutaneous Pertuzumab/Trastuzumab in Patients With HER2-positive Breast Cancer

NCT06954623Not ApplicableRecruitingPrimary

Partial Breast Re-irradiation for Breast Cancer

NCT06517212Phase 2Recruiting

Tirzepatide Weight Loss for MRD+ Early Breast Cancer

NCT06960291Not ApplicableRecruiting

Sustainable Implementation of the EXCEL Exercise Oncology Program Across Canada

NCT06606730Phase 3RecruitingPrimary

Personalizing the Use of Pembrolizumab for Patients Who Have a Strong Response in Early Triple Negative Breast Cancer

NCT07018505Not Yet Recruiting

EpCAM-Targeted Surface-Enhanced Raman Spectroscopy Nanotags for Rapid Evaluation of Surgical Margins and Sentinel Lymph Node Metastasis Status in Breast Cancers

NCT06956443Not Yet RecruitingPrimary

Prediction of ICG for Skin Necrosis in Mastectomy With Immediate Reconstruction

NCT06943313Enrolling By InvitationPrimary

Breast Cancer PET/CT Imaging With 68Ga-pAKTi

NCT06811870Phase 1RecruitingPrimary

A Phase II Single-Arm Clinical Study to Explore the Efficacy and Safety of Hyperbaric Oxygen in the Neoadjuvant Treatment of Breast Cancer Patients

NCT06856876Not ApplicableCompletedPrimary

Examining the Effectiveness of Multidisciplinary Care Teams in Improving Outcomes for Breast Cancer Patients

NCT06825975Not ApplicableNot Yet RecruitingPrimary

A Phase II Single-Arm Clinical Study to Explore the Efficacy and Safety of Hyperbaric Oxygen in the Neoadjuvant Treatment of Triple-Negative and HER2+ Breast Cancer Patients

NCT06825949Not ApplicableNot Yet RecruitingPrimary

A Clinical Study to Explore the Efficacy and Safety of Hyperbaric Oxygen in the Neoadjuvant Treatment of Hormone Receptor Positive Breast Cancer Patients

NCT06819501Not ApplicableNot Yet RecruitingPrimary

Hyperbaric Oxygen Therapy for Peripheral Neuropathy Due to Paclitaxel Analogs

NCT06805812Recruiting

Predicting clinicAL outcoMes During First-line CDK4/6 Inhibitors Plus Endocrine Therapy in Patients With Advanced Hormone REceptor-poSitive HER2-negative Breast Cancer: the Retrospective-prospective Multicenter Italian PALMARES-2 Study

NCT01291420Phase 1Completed

Dendritic Cell Vaccination for Patients with Solid Tumors

NCT06662864CompletedPrimary

Study on Sleep, Lifestyle and Quality of Life in Women With Breast Cancer

NCT03667417RecruitingPrimary

Genetic Predisposition to Breast and Ovarian Cancer: Prospective Study of BRCAx Gene Mutation

NCT00248911Not ApplicableCompletedPrimary

The Effect Of Meditation On Quality Of Life In Women With Breast Cancer And Other Gynecological Cancers

NCT00721903Not ApplicableCompletedPrimary

Three Dimensional (3D) Ultrasound in Predicting Response to Breast Cancer Therapies

Showing all 19 trials

Research Network

Activity Timeline